Back to Blog

November 23, 2024

TikaDevice improved PTA sales by 49% year on year

A medical device company became the first company to receive FDA approval for a drug-coated balloon catheter.

TikaDevice improved PTA sales by 49% year on year

Sales representatives needed to understand which interventional cardiologists and cardiac centers to target and in what order.

Customer Challenges - 

  • This company is the first one to launch the product had just 12 months to capture the market before their competitor launched a similar but well-publicized product. 
  • Essential sales information was not easily accessible and customer inventory and contract data were typically only available through complicated and time-consuming internal processes.
  • In addition, the current data was not presented in an actionable or easily readable format. As data was contained in a variety of sources that were not easily accessible.
  • Team collaboration was difficult to execute.

Download the case study to read how the TikaDevice platform helped micro-target cardiologists and improved PTA (Percutaneous transluminal angioplasty) sales by 49% year-on-year. 

 

CASE STUDY

Browse other Case Studies

November 23, 2024

TikaDevice improved PTA sales by 49% year on year

Sales representatives needed to understand which interventional cardiologists and cardiac centers to target and in what order. Customer Challenges - This company is the first one to launch the.

November 23, 2024

Sales increased by 14% in the first year, thanks to TikaDevice

The sales team of 900 was under incredible pressure to understand and stay informed about every individual customer. Representatives had to understand their current inventory, buying habits, contract.

November 23, 2024

TIkaNAM supported revenue increase through visibility into contract compliance

Using spreadsheets to manage contracts and pricing hindered the team from operating strategically. Their previous BI software did not provide adequate access to all the important time-critical data.